Medication info

Pregabalin Capsule 150 mg (Pregabalin)

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Pregabalin›150mg / 1 capsule
Manufacturer / importer
Medix Pharmaceutical Co., Ltd.
Appearance
A hard capsule with a white upper and white lower part filled with powder that is white to light yellow.
Packaging
30 capsules/bottle
Approval status
Expired

MFDS item code 201901242 · Approved 2019.02.26

This product's status changed to Expired on 2024.02.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
Who takes it
Adults
Adult dose
Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, with or without food. Since this medicine is mainly excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg per day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased to 225 mg twice daily (450 mg per day) within 1 week. Clinical studies were also conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is mainly excreted by the kidneys as unchanged drug. Since clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. Creatinine clearance (ml/min)* *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function

Ingredients

Manufacturer
Medix Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures

  • Peripheral neuropathic pain
  • central neuropathic pain
  • epilepsy
  • partial seizures
  • fibromyalgia.
View approved original text

This medicine is used for the treatment of peripheral and central neuropathic pain in adults. It is also effective as an adjunctive treatment for partial seizures with or without secondary generalization in patients with epilepsy. Additionally, it is employed in the treatment of fibromyalgia. It mainly helps manage neurological disorders and chronic pain, thereby improving patients' quality of life.

How to take

Adult dose

Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, with or without food. Since this medicine is mainly excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg per day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased to 225 mg twice daily (450 mg per day) within 1 week. Clinical studies were also conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is mainly excreted by the kidneys as unchanged drug. Since clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. Creatinine clearance (ml/min)* *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function

Precautions

This medication may increase the risk of suicidal thoughts or behaviors, so it is important to monitor for mood changes or abnormal behaviors during treatment. Patients who are hypersensitive to this drug or have genetic conditions such as lactose intolerance, lactase deficiency, and glucose-galactose malabsorption should not take it. Diabetic patients may experience weight gain after taking this medication and may need to adjust their blood glucose management medications accordingly. If symptoms of angioedema, such as swelling of the face, mouth, or neck, occur, this medication should be discontinued immediately. Elderly patients are at higher risk of falls or accidents due to dizziness or drowsiness caused by this medication, requiring caution. Temporary blurred vision or changes in vision may occur, and these symptoms may improve upon discontinuation of the drug. Discontinuing this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so it is essential not to stop suddenly. There is a potential for drug abuse or dependence; thus, patients with a history of mental illness or substance abuse should exercise special caution. Patients with impaired renal function may require dosage adjustments. Patients with severe heart disease should consult a physician before taking this medication, and those with heart failure should use it cautiously. When taken with opioid analgesics, there is an increased risk of central nervous system depressant effects, such as respiratory depression, so caution is warranted. Patients with respiratory or renal diseases, as well as elderly patients, have a higher risk of severe respiratory depression, necessitating careful administration. In early pregnancy, this medication may pose a risk of congenital malformations to the fetus; thus, women who are pregnant or planning to become pregnant should consult a doctor before use. During treatment, it is advisable to avoid hazardous activities like driving or operating machinery. If severe skin rash or allergic reactions occur, discontinuation and notification to healthcare personnel are required. This medication has few interactions with other drugs; however, taking it with alcohol or central nervous system depressants may worsen drowsiness or dizziness. Women who are breastfeeding should carefully consider the use of this medication as it can be transferred to breast milk. In cases of overdose, symptoms such as drowsiness, confusion, and depressive symptoms may occur, and treatment such as hemodialysis may be necessary.

Side effects

Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, swelling around the mouth, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorder, blurred vision, vision changes, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, depression, pain, sweating, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, appetite loss, hypoglycemia, confusion, disorientation, irritability, depression, euphoria, difficulty finding appropriate terms, hallucinations, abnormal dreams, increased libido, panic attacks, loss of inhibition, apathy, dizziness, drowsiness, ataxia, motor coordination disturbance, balance disorders, amnesia, attention disorder, memory impairment, tremors, dysarthria, sensory disturbances, sensory loss, sedation, somnolence, cognitive impairment, nystagmus, speech disorders, clonic contractions, decreased reflexes, motor abnormalities, psychomotor agitation, position-related dizziness, hypersensitivity, burning sensation, activity tremors, fainting, confusion, motor retardation, olfactory disturbances, taste loss, writing difficulties, blurred vision, diplopia, loss of indirect vision, visual disturbances, visual field loss, photopsia, dry eyes, eye swelling, decreased vision, eye pain, eye fatigue, increased tear production, eye irritation, mydriasis, change in depth perception during vibration, strabismus, brightness of vision, vertigo, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, shortness of breath, nasal bleeding, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux disease, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweats, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, neck pain, muscle stiffness, rhabdomyolysis, urinary disorders, urinary incontinence, decreased urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, breast discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falling, feeling drunk, sensory abnormalities, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, increased blood glucose, decreased platelet count, decreased serum potassium, weight loss, increased serum creatinine, decreased white blood cell count, headache, keratitis, pulmonary edema, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confused state, agitation, restlessness, seizures, shock, anaphylactic-like symptoms, mucocutaneous syndrome, erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. The recommended storage temperature is room temperature between 15°C and 30°C. This helps to maintain the drug's efficacy over time.

Appearance and packaging

Appearance

A hard capsule with a white upper and white lower part filled with powder that is white to light yellow.

Package unit

30 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.